Claudine Guerin-Marchand

This inventor holds 7 USPTO granted patents. Top assignee: Institut Pasteur. Active years: 1997-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Claudine Guerin-Marchand. Retrieved from https://idiyas.com/inventor/claudine-guerin-marchand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 57.1

Average Co-Inventor Count = 2.0

ph-index = 4

Forward Citations = 44(Granted Patents)

Company Filing History:

7 out of 898

Institut Pasteur

patents

Years Active: 1997-2008

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7438917 - [object Object] (2008-10-21),

2. 7332595 - DNA sequences encoding peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes (2008-02-19),

3. 7087231 - [object Object] (2006-08-08),

4. 6319502 - Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes (2001-11-20),

5. 6270771 - Peptide sequences specific for the hepatic stages of P. falciparum bearing epitopes capable of stimulating the T lymphocytes (2001-08-07),

6. 6100067 - Molecules containing at least one peptide sequence carrying one or (2000-08-08),

7. 5690941 - Molecules containing at least one peptide sequence carrying one or (1997-11-25),

Title: Claudine Guerin-Marchand: Innovator in Malaria Diagnostics

Introduction

Claudine Guerin-Marchand is a prominent inventor based in Paris, France. She has made significant contributions to the field of in vitro diagnostics, particularly in the fight against malaria. With a total of 7 patents to her name, her work has the potential to impact public health positively.

Latest Patents

Her latest patents focus on innovative methods for diagnosing malaria. One notable invention relates to an in vitro diagnostic method that involves placing a tissue or biological fluid from an individual in contact with a specific molecule or polypeptide composition. This composition includes peptide sequences that correspond to T epitopes of proteins associated with malaria. The method allows for the detection of antigen-antibody complexes formed during an immunological reaction. Another significant patent discloses isolated DNA sequences that encode polypeptides characterized by T epitopes, which are crucial for stimulating T lymphocytes against malaria.

Career Highlights

Claudine works at the prestigious Institut Pasteur, where she continues to advance her research in infectious diseases. Her dedication to innovation in diagnostics has positioned her as a key figure in the scientific community.

Collaborations

She collaborates with Pierre Druilhe, a fellow researcher, to further enhance the understanding and treatment of malaria.

Conclusion

Claudine Guerin-Marchand's contributions to malaria diagnostics exemplify the vital role of innovation in healthcare. Her patents and ongoing research efforts are paving the way for improved diagnostic methods that could save countless lives.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]